227 related articles for article (PubMed ID: 30582694)
41. Discovery of Novel Oral Protein Synthesis Inhibitors of Mycobacterium tuberculosis That Target Leucyl-tRNA Synthetase.
Palencia A; Li X; Bu W; Choi W; Ding CZ; Easom EE; Feng L; Hernandez V; Houston P; Liu L; Meewan M; Mohan M; Rock FL; Sexton H; Zhang S; Zhou Y; Wan B; Wang Y; Franzblau SG; Woolhiser L; Gruppo V; Lenaerts AJ; O'Malley T; Parish T; Cooper CB; Waters MG; Ma Z; Ioerger TR; Sacchettini JC; Rullas J; Angulo-Barturen I; Pérez-Herrán E; Mendoza A; Barros D; Cusack S; Plattner JJ; Alley MR
Antimicrob Agents Chemother; 2016 Oct; 60(10):6271-80. PubMed ID: 27503647
[TBL] [Abstract][Full Text] [Related]
42. Identification of a novel class of small compounds with anti-tuberculosis activity by in silico structure-based drug screening.
Taira J; Morita K; Kawashima S; Umei T; Baba H; Maruoka T; Komatsu H; Sakamoto H; Sacchettini JC; Aoki S
J Antibiot (Tokyo); 2017 Nov; 70(11):1057-1064. PubMed ID: 28951604
[TBL] [Abstract][Full Text] [Related]
43. Pyrrolidinone and pyrrolidine derivatives: Evaluation as inhibitors of InhA and Mycobacterium tuberculosis.
Matviiuk T; Madacki J; Mori G; Orena BS; Menendez C; Kysil A; André-Barrès C; Rodriguez F; Korduláková J; Mallet-Ladeira S; Voitenko Z; Pasca MR; Lherbet C; Baltas M
Eur J Med Chem; 2016 Nov; 123():462-475. PubMed ID: 27490025
[TBL] [Abstract][Full Text] [Related]
44. Secondary metabolites from Tetracera potatoria stem bark with anti-mycobacterial activity.
Fomogne-Fodjo MC; Ndinteh DT; Olivier DK; Kempgens P; van Vuuren S; Krause RW
J Ethnopharmacol; 2017 Jan; 195():238-245. PubMed ID: 27864111
[TBL] [Abstract][Full Text] [Related]
45. Synthesis of methyl 5-S-alkyl-5-thio-D-arabinofuranosides and evaluation of their antimycobacterial activity.
Sanki AK; Boucau J; Srivastava P; Adams SS; Ronning DR; Sucheck SJ
Bioorg Med Chem; 2008 May; 16(10):5672-82. PubMed ID: 18450455
[TBL] [Abstract][Full Text] [Related]
46. L-proline-catalysed facile green protocol for the synthesis and antimycobacterial evaluation of [1,4]-thiazines.
Indumathi S; Perumal S; Banerjee D; Yogeeswari P; Sriram D
Eur J Med Chem; 2009 Dec; 44(12):4978-84. PubMed ID: 19781824
[TBL] [Abstract][Full Text] [Related]
47. Design, synthesis and characterization of novel inhibitors against mycobacterial β-ketoacyl CoA reductase FabG4.
Banerjee DR; Dutta D; Saha B; Bhattacharyya S; Senapati K; Das AK; Basak A
Org Biomol Chem; 2014 Jan; 12(1):73-85. PubMed ID: 24129589
[TBL] [Abstract][Full Text] [Related]
48. Diarylquinolines, synthesis pathways and quantitative structure--activity relationship studies leading to the discovery of TMC207.
Guillemont J; Meyer C; Poncelet A; Bourdrez X; Andries K
Future Med Chem; 2011 Sep; 3(11):1345-60. PubMed ID: 21879841
[TBL] [Abstract][Full Text] [Related]
49. Antimycobacterial activities of novel 2-(sub)-3-fluoro/nitro-5,12-dihydro-5-oxobenzothiazolo[3,2-a]quinoline-6-carboxylic acid.
Dinakaran M; Senthilkumar P; Yogeeswari P; China A; Nagaraja V; Sriram D
Bioorg Med Chem; 2008 Mar; 16(6):3408-18. PubMed ID: 18304818
[TBL] [Abstract][Full Text] [Related]
50. Synthesis and antimycobacterial activity of novel camphane-based agents.
Stavrakov G; Philipova I; Valcheva V; Momekov G
Bioorg Med Chem Lett; 2014 Jan; 24(1):165-7. PubMed ID: 24332625
[TBL] [Abstract][Full Text] [Related]
51. Antimycobacterial activities of novel fluoroquinolones.
Senthilkumar P; Dinakaran M; Yogeeswari P; China A; Nagaraja V; Sriram D
Biomed Pharmacother; 2009 Jan; 63(1):27-35. PubMed ID: 18031974
[TBL] [Abstract][Full Text] [Related]
52. Rational Design and Synthesis of Thioridazine Analogues as Enhancers of the Antituberculosis Therapy.
Pieroni M; Machado D; Azzali E; Santos Costa S; Couto I; Costantino G; Viveiros M
J Med Chem; 2015 Aug; 58(15):5842-53. PubMed ID: 26197353
[TBL] [Abstract][Full Text] [Related]
53. Machine learning and docking models for Mycobacterium tuberculosis topoisomerase I.
Ekins S; Godbole AA; Kéri G; Orfi L; Pato J; Bhat RS; Verma R; Bradley EK; Nagaraja V
Tuberculosis (Edinb); 2017 Mar; 103():52-60. PubMed ID: 28237034
[TBL] [Abstract][Full Text] [Related]
54. Polyfluorinated salicylic acid analogs do not interfere with siderophore biosynthesis.
Hegde P; Orimoloye MO; Sharma S; Engelhart CA; Schnappinger D; Aldrich CC
Tuberculosis (Edinb); 2023 May; 140():102346. PubMed ID: 37119793
[TBL] [Abstract][Full Text] [Related]
55. Assay development for identifying inhibitors of the mycobacterial FadD32 activity.
Galandrin S; Guillet V; Rane RS; Léger M; N R; Eynard N; Das K; Balganesh TS; Mourey L; Daffé M; Marrakchi H
J Biomol Screen; 2013 Jun; 18(5):576-87. PubMed ID: 23364516
[TBL] [Abstract][Full Text] [Related]
56. Synthetic thiosemicarbazones as a new class of Mycobacterium tuberculosis protein tyrosine phosphatase A inhibitors.
Sens L; de Souza ACA; Pacheco LA; Menegatti ACO; Mori M; Mascarello A; Nunes RJ; Terenzi H
Bioorg Med Chem; 2018 Nov; 26(21):5742-5750. PubMed ID: 30389409
[TBL] [Abstract][Full Text] [Related]
57. Microbiology. TB--a new target, a new drug.
Cole ST; Alzari PM
Science; 2005 Jan; 307(5707):214-5. PubMed ID: 15653490
[No Abstract] [Full Text] [Related]
58. Oxadiazolone derivatives, new promising multi-target inhibitors against M. tuberculosis.
Nguyen PC; Delorme V; Bénarouche A; Guy A; Landry V; Audebert S; Pophillat M; Camoin L; Crauste C; Galano JM; Durand T; Brodin P; Canaan S; Cavalier JF
Bioorg Chem; 2018 Dec; 81():414-424. PubMed ID: 30212765
[TBL] [Abstract][Full Text] [Related]
59. In vitro and ex vivo activity of new derivatives of acetohydroxyacid synthase inhibitors against Mycobacterium tuberculosis and non-tuberculous mycobacteria.
Sohn H; Lee KS; Ko YK; Ryu JW; Woo JC; Koo DW; Shin SJ; Ahn SJ; Shin AR; Song CH; Jo EK; Park JK; Kim HJ
Int J Antimicrob Agents; 2008 Jun; 31(6):567-71. PubMed ID: 18337064
[TBL] [Abstract][Full Text] [Related]
60. Evaluation of Mycobacterium smegmatis as a possible surrogate screen for selecting molecules active against multi-drug resistant Mycobacterium tuberculosis.
Chaturvedi V; Dwivedi N; Tripathi RP; Sinha S
J Gen Appl Microbiol; 2007 Dec; 53(6):333-7. PubMed ID: 18187888
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
